| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $590K | — |
| Cost of Revenue | $405K | — |
| Gross Profit | $185K | — |
| R&D Expense | $147K | +40.5% |
| SG&A Expense | $2.2M | +104.9% |
| Interest Expense | $103K | — |
| Pre-tax Income | -$7.7M | -92.9% |
| Income Tax | $31K | — |
| Net Income | -$7.7M | -24.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $572K | — |
| Accounts Receivable | $245K | +4551.7% |
| Inventory | $95K | — |
| Current Assets | $6.9M | +13.6% |
| Total Assets | $12.9M | +43.1% |
| Current Liabilities | $3.9M | +119.1% |
| Total Liabilities | $5.0M | +115.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.9M | -8.1% |
| Capital Expenditures | $442K | +4728.1% |
| Investing Cash Flow | -$2.8M | -352.9% |
| Financing Cash Flow | $10.1M | +49.7% |
| Free Cash Flow | -$6.4M | -16.0% |
| $7.8M |
| +17.7% |